Intuitive Biosciences
Supporting biomedical research through serological testing services and kits.
Supporting biomedical research through serological testing services and kits.
Intuitive Biosciences is a biotechnology startup based in the United States that focuses on supporting biomedical research through serological testing services and kits. Since their establishment in 2012, the company has been providing solutions to monitor nonhuman primate health, including screening for infectious diseases like tuberculosis and SARS-CoV-2.
Intuitive Biosciences offers a comprehensive immunoassay platform, which is available as a turnkey system or OEM, inclusive of consumables, content, SilverQuant detection reagents, analysis instruments, and reporting software. The startup recently received a $75.00K grant investment from SBIR Advance on 10 June 2024.
With a clear emphasis on providing essential tools for the biomedical research community, Intuitive Biosciences is positioned to address critical needs in the health care and biotechnology industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $75.00K | 1 | SBIR Advance | 10 Jun 2024 |
| Venture Round | Unknown | 1 |
|
01 Nov 2019 |
| Venture Round | $1.33M | - | 04 Jun 2015 | |
| Debt Financing | $486.86K | - | 01 Aug 2014 | |
| Venture Round | $572.73K | - | 12 Apr 2013 |
No recent news or press coverage available for Intuitive Biosciences.
We care about your data, and we'd love to use cookies make your experience better.
